The Impact of Repeated Rounds of Mass Drug Administration with Diethylcarbamazine Plus Albendazole on Bancroftian Filariasis in Papua New Guinea

被引:68
|
作者
Weil, Gary J. [1 ]
Kastens, Will [2 ]
Susapu, Melinda [3 ]
Laney, Sandra J. [4 ]
Williams, Steven A. [4 ]
King, Christopher L. [2 ]
Kazura, James W. [2 ]
Bockarie, Moses J. [2 ,3 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO 63130 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Papua New Guinea Inst Med Res, Madang, Papua N Guinea
[4] Smith Coll, Northampton, MA 01063 USA
来源
PLOS NEGLECTED TROPICAL DISEASES | 2008年 / 2卷 / 12期
关键词
D O I
10.1371/journal.pntd.0000344
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: This study employed various monitoring methods to assess the impact of repeated rounds of mass drug administration (MDA) on bancroftian filariasis in Papua New Guinea, which has the largest filariasis problem in the Pacific region. Methodology/Principal Findings: Residents of rural villages near Madang were studied prior to and one year after each of three rounds of MDA with diethylcarbamazine plus albendazole administered per World Health Organization (WHO) guidelines. The mean MDA compliance rate was 72.9%. Three rounds of MDA decreased microfilaremia rates (Mf, 1 ml night blood by filter) from 18.6% pre-MDA to 1.3% after the third MDA (a 94% decrease). Mf clearance rates in infected persons were 71%, 90.7%, and 98.1% after 1, 2, and 3 rounds of MDA. Rates of filarial antigenemia assessed by card test (a marker for adult worm infection) decreased from 47.5% to 17.1% (a 64% decrease) after 3 rounds of MDA. The filarial antibody rate (IgG(4) antibodies to Bm14, an indicator of filarial infection status and/or exposure to mosquito-borne infective larvae) decreased from 59.3% to 25.1% (a 54.6% decrease). Mf, antigen, and antibody rates decreased more rapidly in children,11 years of age (by 100%, 84.2%, and 76.8%, respectively) relative to older individuals, perhaps reflecting their lighter infections and shorter durations of exposure/infection prior to MDA. Incidence rates for microfilaremia, filarial antigenemia, and antifilarial antibodies also decreased significantly after MDA. Filarial DNA rates in Anopheles punctulatus mosquitoes that had recently taken a blood meal decreased from 15.1% to 1.0% (a 92.3% decrease). Conclusions/Significance: MDA had dramatic effects on all filariasis parameters in the study area and also reduced incidence rates. Follow-up studies will be needed to determine whether residual infection rates in residents of these villages are sufficient to support sustained transmission by the An. punctulatus vector. Lymphatic filariasis elimination should be feasible in Papua New Guinea if MDA can be effectively delivered to endemic populations.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Lymphatic Filariasis Control in Tanzania: Effect of Repeated Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission
    Simonsen, Paul E.
    Pedersen, Erling M.
    Rwegoshora, Rwehumbiza T.
    Malecela, Mwelecele N.
    Derua, Yahya A.
    Magesa, Stephen M.
    PLOS NEGLECTED TROPICAL DISEASES, 2010, 4 (06):
  • [42] LONG-TERM IMPACT OF REPEATED MDA ON LYMPHATIC FILARIASIS DISEASE IN PAPUA NEW GUINEA
    Kazura, James W.
    Thomsen, Edward
    Baea, Manasseh
    Zimmerman, Peter A.
    King, Christopher L.
    Siba, Peter
    Tisch, Daniel J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (05): : 20 - 20
  • [43] Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
    Khaemba, Christabel
    Barry, Abbie
    Omondi, Wyckliff P.
    Bota, Kefa
    Matendechero, Sultani
    Wandera, Cecilia
    Siyoi, Fred
    Kirui, Elvis
    Oluka, Margaret
    Nambwa, Pamela
    Gurumurthy, Parthasarathi
    Njenga, Sammy M.
    Guantai, Anastacia
    Aklillu, Eleni
    PHARMACEUTICALS, 2021, 14 (03)
  • [44] Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya
    Njenga, S. M.
    Wamae, C. N.
    Njomo, D. W.
    Mwandawiro, C. S.
    Molyneux, D. H.
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2008, 102 (10) : 1017 - 1024
  • [45] Impact of mass drug administration on Wuchereria bancrofti infection rates in mosquitoes in papua new guinea
    Laney, Sandra J.
    Susapu, Melinda
    Weil, Gary J.
    Williams, Steven A.
    Bockarie, Moses J.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 73 (06): : 175 - 175
  • [46] Mass treatment with ivermectin for filariasis control in Papua New Guinea: impact on mosquito survival
    Bockarie, MJ
    Hii, JLK
    Alexander, NDE
    Bockarie, F
    Dagoro, H
    Kazura, JW
    Alpers, MP
    MEDICAL AND VETERINARY ENTOMOLOGY, 1999, 13 (02) : 120 - 123
  • [47] BANCROFTIAN FILARIASIS IN AN ISOLATED HUNTER GATHERER SHIFTING HORTICULTURIST GROUP IN PAPUA-NEW-GUINEA
    DESOWITZ, RS
    JENKINS, C
    ANIAN, G
    BULLETIN OF THE WORLD HEALTH ORGANIZATION, 1993, 71 (01) : 55 - 58
  • [48] DIETHYLCARBAMAZINE IN THE CONTROL OF BANCROFTIAN FILARIASIS IN THE OK-TEDI AREA OF PAPUA-NEW-GUINEA - PHASE-2 - ANNUAL SINGLE-DOSE TREATMENT
    SCHUURKAMP, GJ
    KEREU, RK
    BULUNGOL, PK
    KAWERENG, A
    SPICER, PE
    PAPUA NEW GUINEA MEDICAL JOURNAL, 1994, 37 (02) : 65 - 81
  • [49] COMMUNITY EFFECTIVENESS AND INDIVIDUAL EFFICACY OF IVERMECTIN, DIETHYLCARBAMAZINE AND ALBENDAZOLE MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS, SCABIES AND SOIL TRANSMITTED HELMINTHS IN FIJI
    Hardy, Myra
    Samuela, Josaia
    Kama, Mike
    Tuicakau, Meciusela
    Romani, Lucia
    Whitfeld, Margot
    Kaldor, John
    Robinson, Leanne J.
    Steer, Andrew
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 395 - 395
  • [50] Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil
    da Silva, Jennifer S. F.
    Braga, Cynthia
    Duarte, Felipe M.
    Oliveira, Paula
    Luna, Carlos Feitosa
    Marcondes, Marcia
    Araujo, Josue
    Grilis, Maria Rosangela
    de Souza Melo, Paula Fernanda A.
    Brandao, Eduardo
    Rocha, Abraham
    PATHOGENS AND GLOBAL HEALTH, 2018, 112 (05) : 274 - 280